The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
A CHEK2 Genetic Variant Contributing to a Substantial Fraction of Familial Breast Cancer
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The DNA damage response: putting checkpoints in perspective
Zhou, B.-B. S., & Elledge, S. J. (2000) · Nature · doi:10.1038/35044005 · Cited by 3,213
Linkage of ATM to Cell Cycle Regulation by the Chk2 Protein Kinase
Matsuoka, S. (1998) · Science · doi:10.1126/science.282.5395.1893 · Cited by 1,322
The CHEK2-Breast Cancer Consortium (2002) · Nature Genetics · doi:10.1038/ng879 · Cited by 1,104
Shieh, S.-Y., Ahn, J., Tamai, K., Taya, Y., & Prives, C. (2000) · Genes & Development · doi:10.1101/gad.14.3.289 · Cited by 972
Heterozygous Germ Line hCHK2 Mutations in Li-Fraumeni Syndrome
Bell, D. W., Varley, J. M., Szydlo, T. E., Kang, D. H., Wahrer, D. C. R., Shannon, K. E., Lubratovich, M., Verselis, S. J., Isselbacher, K. J., Fraumeni, J. F., et al. (1999) · Science · doi:10.1126/science.286.5449.2528 · Cited by 904
Ataxia telangiectasia-mutated phosphorylates Chk2 in vivo and in vitro
Matsuoka, S., Rotman, G., Ogawa, A., Shiloh, Y., Tamai, K., & Elledge, S. J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.190030497 · Cited by 829
Chk2/hCds1 functions as a DNA damage checkpoint in G1by stabilizing p53
Chehab, N. H., Malikzay, A., Appel, M., & Halazonetis, T. D. (2000) · Genes & Development · doi:10.1101/gad.14.3.278 · Cited by 805
The many substrates and functions of ATM.
Kastan, M. B., & Lim, D.-S. (2000) · Nature Reviews Molecular Cell Biology · doi:10.1038/35043058 · Cited by 779
A systematic review of genetic polymorphisms and breast cancer risk.
Dunning, A., Healey, C. S., Pharoah, P., Teare, M. D., Ponder, B. A. J., & Easton, D. F. (1999) · PubMed · Cited by 539
hCds1-mediated phosphorylation of BRCA1 regulates the DNA damage response
Lee, J.-S., Collins, K. M., Brown, A. L., Lee, C.-H., & Chung, J. H. (2000) · Nature · doi:10.1038/35004614 · Cited by 529
A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes
Antoniou, A. C., Pharoah, P. D. P., McMullan, G., Day, N. E., Stratton, M. R., Peto, J., Ponder, B. J., & Easton, D. F. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600008 · Cited by 495
Chk2 kinase — a busy messenger
Bartek, J., Falck, J., & Lukas, J. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35103059 · Cited by 403
Self-citationAntoniou, A. C., Pharoah, P. D. P., McMullan, G., Day, N. E., Ponder, B. A. J., & Easton, D. (2001) · Genetic Epidemiology · doi:10.1002/gepi.1014 · Cited by 289
Syrjakoski, K. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.18.1529 · Cited by 197
Syvänen, A. C., Sajantila, A., & Lukka, M. (1993) · Europe PMC (PubMed Central) · Cited by 195
Vahteristo, P., Tamminen, A., Karvinen, P., Eerola, H., Eklund, C., Aaltonen, L. A., BLOMQVIST, C. P., Aittomäki, K., & Nevanlinna, H. A. (2001) · PubMed · Cited by 180
Self-citationCharacterization of Tumor-associated Chk2 Mutations
Wu, X., Webster, S. R., & Chen, J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009727200 · Cited by 175
Vehmanen, P. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.13.2309 · Cited by 166
Destabilization of CHK2 by a missense mutation associated with Li-Fraumeni Syndrome.
Lee, S. B., Kim, S. H., Bell, D. W., Wahrer, D. C. R., Schiripo, T. A., Jorczak, M. M., Sgroi, D. C., Garber, J. E., Li, F. P., Nichols, K. E., et al. (2001) · PubMed · Cited by 160
Lukas, C., Bártková, J., Latella, L., Falck, J., Mailand, N., Schroeder, T., Sehested, M., Lukáš, J., & Bártek, J. (2001) · PubMed · Cited by 133
Familial breast cancer in southern Finland
Eerola, H., BLOMQVIST, C. P., Pukkala, ., Pyrhönen, S. O., & Nevanlinna, H. A. (2000) · European Journal of Cancer · doi:10.1016/s0959-8049(00)00093-9 · Cited by 103
Self-citationMiller, C. W., Ikezoe, T., Krug, U. O., Hofmann, W., Tavor, S., Vegesna, V. R., Tsukasaki, K., Takeuchi, S., & Koeffler, H. P. (2001) · Genes Chromosomes and Cancer · doi:10.1002/gcc.1207 · Cited by 98
Haruki, N., Saito, H., Tatematsu, Y., Konishi, H., Harano, T., Masuda, A., Osada, H., Fujii, Y., & Takahashi, T. (2000) · PubMed · Cited by 80
Chk2 tumour suppressor protein in human spermatogenesis and testicular germ-cell tumours
Bártková, J., Falck, J., Meyts, E. R., Skakkebæk, N. E., Lukas, J., & Bártek, J. (2001) · Oncogene · doi:10.1038/sj.onc.1204746 · Cited by 69
Hofmann, W., Miller, C. W., Tsukasaki, K., Tavor, S., Ikezoe, T., Hoelzer, D. F., Takeuchi, S., & Koeffler, H. P. (2001) · Leukemia Research · doi:10.1016/s0145-2126(00)00130-2 · Cited by 60
Analysis of the CHK2 Gene in Lymphoid Malignancies
Tavor, S., Takeuchi, S., Tsukasaki, K., Miller, C. W., Hofmann, W. K., Ikezoe, T., SAID, J. W., & Koeffler, H. P. (2001) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428190109064610 · Cited by 34
Cited by
ATM and related protein kinases: safeguarding genome integrity
Shiloh, Y. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1011 · Cited by 2,577
Chk1 and Chk2 kinases in checkpoint control and cancer
Bartek, J., & Lukas, J. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00110-7 · Cited by 1,513
Self-citationCell death by mitotic catastrophe: a molecular definition
Castedo, M., Perfettini, J.-L., Roumier, T., Andreau, K., Medema, R., & Kroemer, G. (2004) · Oncogene · doi:10.1038/sj.onc.1207528 · Cited by 1,269
BRCA1 and BRCA2: 1994 and beyond
Narod, S. A., & Foulkes, W. D. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1431 · Cited by 967
Polygenes, Risk Prediction, and Targeted Prevention of Breast Cancer
Pharoah, P. D. P., Antoniou, A. C., Easton, D. F., & Ponder, B. A. J. (2008) · New England Journal of Medicine · doi:10.1056/nejmsa0708739 · Cited by 618
Metadata
- Authors
- Vahteristo, P., Bartkova, J., Eerola, H., Syrjäkoski, K., Ojala, S., Kilpivaara, O., Tamminen, A., Kononen, J., Aittomäki, K., Heikkilä, P., Holli, K., Blomqvist, C., Bartek, J., Kallioniemi, O.-P., & Nevanlinna, H.
- Venue
- The American Journal of Human Genetics
- Publisher
- Elsevier BV
- Published
- 2002-08
- Volume
- 71
- Issue
- 2
- Pages
- 432-438
- ISSN
- 0002-9297 (ISSN-L)
- OpenAlex
- W2058005740
- Cited by
- 467
- References
- 26
- FWCI
- 18.18
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.